Glutamate antagonists |
— |
Glutamate |
Attenuation of noise-induced TTS |
Khan et al. (2000) |
Kynurenate |
AMPA |
Protective effect on NIHL |
Puel et al. (1998) |
Caroverine |
NMDA & AMPA |
Reduction of hearing impairment in NIHL |
Chen et al. (2003) |
Chen et al. (2004) |
MK801 |
NMDA |
Protection in amikacin-induced hearing loss |
Duan et al. (2000) |
Memantine |
NMDA |
Prevention of toxic damage to hair cells in amikacin-induced hearing loss |
Pavlidis et al. (2014) |
Kinase |
D-JNKI-1 |
Blocking of MAPK-JNK signal pathway |
Prevention in a dose-dependent manner of hair cell death and permanent hearing loss induced by neomycin after cochlear application |
Wang et al. (2003b) see Eshraghi et al. (2007). |
Prevention of noise-induced permanent hearing loss by a direct cochlear application |
Wang et al. (2003b) |
Prevention of hair cell death and PTS induced noise by RWM application |
Wang et al. (2007b) |
Caspase inhibitors |
z-DEVD-fmk |
caspase-3 |
Prevention of cisplatin-induced hearing loss by intracochlear treatment |
Wang et al. (2004) |
z-LEHD-fmk |
caspase-9 |
z-VAD-FMK |
caspase |
Hearing recovery and reduction of hair cell loss after NIHL |
Abaamrane et al. (2011) |
Enzymes |
MDL28170 |
gamma-secretase inhibitor |
Protective effect on NIHL by direct delivery into the cochlear fluids |
Tona et al. (2014) |
Calpain inhibitors |
BN82270 |
calpain |
Prevention of hair cell degeneration induced by noise by application in cochlear fluids or onto the RWM |
Wang et al. (2007a) |
leupeptin |
calpain |
No effect after a gunshot noise-induced trauma by cochlear infusion |
Abaamrane et al. (2011) |
Adrenocorticotrophic Hormone (ACTH) |
ORG 2766 |
ACTH analogue |
Protection against hair cell loss and hearing loss induced by cisplatin |
Hamers et al. (1994); Smoorenburg et al. (1999); Cardinaal et al. (2000)
|